SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending amid high anticipation for founder Dr. Patrick Soon-Shiong's prime-time interviews and an upcoming investor conference call, with the community speculating on major updates for ANKTIVA and catalysts that could trigger a significant short squeeze.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is a hot topic following substantial new equity financing and strong 2025 retail sales growth, sparking intense debate among the community about whether it's on the cusp of a turnaround or still susceptible to its past financial challenges.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is generating buzz after its AXPAXLI Phase 3 trial demonstrated superiority against Eylea for wet AMD, but an unexpected stock decline has sparked community debate over the drug's commercial differentiation against newer therapies and its safety profile, intensifying persistent buyout speculation.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is experiencing a surge in investor interest following strong financial results that significantly exceeded expectations, alongside positive pipeline updates for its long-acting navenibart program. The community is actively discussing the company's renewed profitability, potential for growth in rare-disease therapies, and the possibility of a short squeeze given high trading volume and notable short interest.

Hawaiian Electric Industries, Inc. is a holding company, which engages in electric utility and non-regulated renewable and sustainable infrastructure businesses. The company was founded by C. Dudley Pratt Jr. in 1981 and is headquartered in Honolulu, HI.

Hawaiian Electric Industries, Inc.

Hawaiian Electric is trending as investors digest its Q4 2025 earnings, showcasing a notable recovery, while closely tracking ongoing wildfire settlement progress and related legal developments. Community discussion is vibrant, with many anticipating a return to pre-fire valuations and dividend reinstatement, although some express caution regarding potential short-term pullbacks despite significant institutional accumulation.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as its offer for Warner Bros. Discovery was deemed superior, leading Netflix to withdraw its competing bid. The community is buzzing with excitement over the formation of a potential new media powerhouse with an expansive content and sports library, while also debating the strategic implications of the significant debt involved.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is seeing intense debate as its PDUFA for a dry eye treatment was extended to March 16, 2026, following an FDA request for data from a trial that missed its primary endpoint, leading bulls to cite a draft label and CEO confidence while bears emphasize past rejections, cash runway concerns, and a key executive's departure.

Aardvark Therapeutics, Inc. operates as a biotechnology company. It engages in the development of a novel, small-molecule therapeutics for the treatment of metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

Aardvark Therapeutics Inc.

Aardvark Therapeutics Inc

Aardvark Therapeutics is trending after voluntarily pausing its Phase 3 HERO trial for ARD-101 in Prader-Willi hyperphagia due to reversible cardiac signals, leading to community discussion around significant downside potential and clinical disapproval.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as its primary competitor, Corcept Therapeutics, received an FDA Complete Response Letter for relacorilant, significantly widening Recorlev's market opportunity in the high-margin Cushing's syndrome space. This, alongside strong preliminary Q4 results and the anticipated Phase 3 entry for XP-8121, is driving community optimism for substantial valuation growth and blockbuster potential.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil Corp is trending as escalating geopolitical tensions in the Middle East fuel widespread speculation about an imminent surge in oil prices and the potential for a massive short squeeze. The community is actively discussing the company's recent debt reduction and improved financial standing, positioning it as a significant oil play amidst market uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


s11gamesnet

S11